Cubist Pharmaceuticals (CBST) shares +14.5% premarket after it granted Teva Pharmaceuticals...

|By:, SA News Editor

Cubist Pharmaceuticals (CBST) shares +14.5% premarket after it granted Teva Pharmaceuticals (TEVA) a license to sell a generic version of its flagship infection fighting drug Cubicin to settle a patent claim it filed against the generic drug maker. (PR)